Research News
View articles by month and year
-
African American Women Have Lower Breast Cancer Survival Rates Than White Women
A large CDC study has found that African American women continue to have lower breast cancer survival rates than white women.
-
Older Women Commonly Treated with Chemotherapy Medicines Used “Off-Label”
A study found that 19% of chemotherapy medicines given to women 65 and older were used off-label.
-
Lower Dose of Radiation Therapy Just as Good as Current Regimen for Early-Stage Breast Cancer
A study compared the standard radiation therapy schedule to shorter, lower-dose radiation schedules and found that the risk of early-stage breast cancer coming back (recurrence) was about the same for all the schedules. The lower-dose schedules also had fewer effects on healthy breast tissue.
-
MarginProbe System Approved by FDA
On Jan. 2, 2013, the U.S. Food and Drug Administration approved the MarginProbe System – a device that helps surgeons decide if all the cancer tissue has been removed during lumpectomy.
-
Vitamin D Levels May Be Reason Some Women Benefit from Zometa Added to Chemo
New results from a large study suggest that postmenopausal women diagnosed with early-stage breast cancer who had adequate vitamin D levels got more benefits from Zometa combined with chemotherapy than women who had low vitamin D levels.
-
Art Therapy and Meditation Can Ease Stress in Women Diagnosed with Breast Cancer
A small study found that art therapy combined with meditation helped ease stress in women diagnosed with breast cancer.
-
Dose-Dense Ellence Regimen Better for High-Risk Breast Cancer Than Early-Stage Breast Cancer
Two studies looking at a dose-dense regimen of Ellence compared to a standard schedule found that the dose-dense regimen is better for high-risk breast cancer.
-
Femara Better Than Tamoxifen for Certain Types of Breast Cancer
Femara was better than tamoxifen in treating postmenopausal women diagnosed with estrogen-receptor-positive, HER2-negative, lobular breast cancer; it was also better at treating luminal B breast cancers.
-
Study Finds Physical Evidence That Chemo Brain is Real
A study found that chemo brain is associated with changes in the way parts of the brain use glucose.
-
Experimental Medicine Seems to Help Treat Estrogen-Receptor-Positive, HER2-Negative, Advanced-Stage Breast Cancer
An early study suggests that an experimental medicine given in combination with Femara offers more benefits in treating advanced-stage, estrogen-receptor-positive, HER2-negative breast cancer than Femara alone.
